SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-15-162493
Filing Date
2015-04-30
Accepted
2015-04-30 17:00:55
Documents
9
Period of Report
2015-06-17
Effectiveness Date
2015-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A d907882ddef14a.htm DEF 14A 337881
2 GRAPHIC g907882g62k76.jpg GRAPHIC 20634
3 GRAPHIC g907882g91c62.jpg GRAPHIC 28220
4 GRAPHIC g907882pc_001.jpg GRAPHIC 4014
5 GRAPHIC g907882pc_002.jpg GRAPHIC 7389
6 GRAPHIC g907882pc_003.jpg GRAPHIC 798
7 GRAPHIC g907882pc_004.jpg GRAPHIC 645
8 GRAPHIC g907882pc_005.jpg GRAPHIC 1076
9 GRAPHIC g907882pc_006.jpg GRAPHIC 5189
  Complete submission text file 0001193125-15-162493.txt   433754
Mailing Address 1 Broadway 14TH FLOOR Cambridge MA 02142
Business Address 1 Broadway 14TH FLOOR Cambridge MA 02142 617-225-4348
Tokai Pharmaceuticals Inc (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36620 | Film No.: 15819904
SIC: 2834 Pharmaceutical Preparations